This compound is a pharmaceutical intermediate designed as a DOTA-based bioconjugation building block. It features a maleimide group for selective coupling with thiol-containing biomolecules and multiple tert-butyl ester-protected carboxyl groups, enabling controlled deprotection and conjugation in research and manufacturing settings.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1613382-10-7
Methyl 4-aminopyridine-3-carboxylate
pharmaceutical intermediate
1-Methanesulfonylpiperazine hydrochloride
pharmaceutical intermediate
(3S)-3-hydroxy-L-lysine
pharmaceutical intermediate
1-(4-fluorophenyl)piperazine hydrochloride
Pharmaceutical intermediate
DOTA-maleimido
bioconjugation reagent for targeted imaging
tert-butyl 2-[4-[2-[2-(2,5-dioxopyrrol-1-yl)ethylamino]-2-oxoethyl]-7,10-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetate
AWBZYCMDPJWQKQ-UHFFFAOYSA-N
CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(=O)NCCN2C(=O)C=CC2=O
—